Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C

被引:23
|
作者
Iwata, Hiroaki [1 ]
Kamaguchi, Mayumi [2 ]
Ujiie, Hideyuki [1 ]
Nishimura, Machiko [1 ]
Izumi, Kentaro [1 ]
Natsuga, Ken [1 ]
Shinkuma, Satoru [1 ]
Nishie, Wataru [1 ]
Shimizu, Hiroshi [1 ]
机构
[1] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Dept Oral Diag & Med, Grad Sch Dent Med, Sapporo, Hokkaido, Japan
关键词
CARCINOMA-CELL-LINE; BLISTER FORMATION; DENDRITIC CELLS; COMPLEMENT ACTIVATION; BASEMENT-MEMBRANE; RHO-GTPASES; ANTIGEN; KERATINOCYTES; AUTOANTIGEN; INTERNALIZATION;
D O I
10.1038/labinvest.2016.108
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Macropinocytosis is an endocytic pathway that is involved in the nonselective fluid uptake of extracellular fluid. Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with autoantibodies to type XVII collagen (COL17), which is a component of hemidesmosome. When keratinocytes are treated with BP-IgG, COL17 internalizes into cells by way of the macropinocytosis. We investigated the mechanism of COL17 macropinocytosis using DJM-1 cells, a cutaneous squamous cell carcinoma cell line. First, non-hemidesmosomal COL17 was preferentially depleted by stimulation with the BP-IgG in the DJM-1 cells. To investigate the signaling involved in COL17-macropinocytosis, the inhibition of small GTPase family members Rac1 and Cdc42 was found to strongly repress COL17 internalization; in addition, the Rho inhibitor also partially blocked that internalization, suggesting these small GTPases are involved in signaling to mediate COL17-macropinocytosis. Western blotting using Phostag-SDS-PAGE demonstrated high levels of COL17 phosphorylation in DJM-1 cells under steady-state condition. Treatment with BP-IgG increased the intracellular calcium level within a minute, and induced the overabundant phosphorylation of COL17. The overabundant phosphorylation of COL17 was suppressed by a protein kinase C (PKC) inhibitor. In addition, PKC inhibitor repressed COL17 endocytosis using cell culture and organ culture systems. Finally, the depletion of COL17 was not observed in the HEK293 cells transfected COL17 without intracellular domain. These results suggest that COL17 internalization induced by BP-IgG may be mediated by a PKC pathway. In summary, BP-IgG initially binds to COL17 distributed on the plasma membrane, and COL17 may be internalized by means of a macropinocytic pathway related to the phosphorylation of the intracellular domain by PKC.
引用
收藏
页码:1301 / 1310
页数:10
相关论文
共 14 条
  • [1] Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes
    Imafuku, Keisuke
    Iwata, Hiroaki
    Kamaguchi, Mayumi
    Izumi, Kentaro
    Natsuga, Ken
    Ujiie, Hideyuki
    Nishie, Wataru
    Shimizu, Hiroshi
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (12) : 1171 - 1174
  • [2] IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180-kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell Attachment
    Iwata, Hiroaki
    Kamio, Naoko
    Aoyama, Yumi
    Yamamoto, Yukari
    Hirako, Yoshiaki
    Owaribe, Katsushi
    Kitajima, Yasuo
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (04) : 919 - 926
  • [3] Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid
    Yamamoto, K
    Inoue, N
    Masuda, R
    Fujimori, A
    Saito, T
    Imajoh-Ohmi, S
    Shinkai, H
    Sakiyama, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (03) : 485 - 492
  • [4] Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid
    Lin, Lan
    Betsuyaku, Tomoko
    Heimbach, Lisa
    Li, Ning
    Rubenstein, David
    Shapiro, Steven D.
    An, Lijia
    Giudice, George J.
    Diaz, Luis A.
    Senior, Robert M.
    Liu, Zhi
    MATRIX BIOLOGY, 2012, 31 (01) : 38 - 44
  • [5] High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa
    Kamaguchi, Mayumi
    Iwata, Hiroaki
    Ujiie, Hideyuki
    Natsuga, Ken
    Nishie, Wataru
    Kitagawa, Yoshimasa
    Shimizu, Hiroshi
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (08) : 1707 - 1715
  • [6] Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models
    Ujiie, Hideyuki
    Yoshimoto, Norihiro
    Natsuga, Ken
    Muramatsu, Ken
    Iwata, Hiroaki
    Nishie, Wataru
    Shimizu, Hiroshi
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [7] Therapeutic potential of recombinant human type XVII collagen in wound healing and bullous pemphigoid: From bench to bedside
    Wang, Suqin
    Huang, Zeyu
    Zhou, Lailai
    Li, Jiajia
    Li, Haihang
    Jiang, Tingting
    Lin, Li
    Zhang, Zhiqiang
    Fang, Yuxia
    Zhang, Ruzhi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 207
  • [8] Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen
    Hayashi, I.
    Shinkuma, S.
    Shimizu, S.
    Natsuga, K.
    Ujiie, H.
    Yasui, C.
    Tsuchiya, K.
    Nishie, W.
    Shimizu, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (05) : 1116 - 1120
  • [9] Characterization of BALB/c mice B lymphocyte autoimmune responses to skin basement membrane component type XVII collagen, the target antigen of autoimmune skin disease bullous pemphigoid
    Xu, LT
    Robinson, N
    Miller, SD
    Chan, LS
    IMMUNOLOGY LETTERS, 2001, 77 (02) : 105 - 111
  • [10] Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2 type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa
    Darling, TN
    McGrath, JA
    Yee, C
    Gatalica, B
    Hametner, R
    Bauer, JW
    PohlaGubo, G
    Christiano, AM
    Uitto, J
    Hintner, H
    Yancey, KB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 463 - 468